Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-201-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July-November 2019
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 021
- Report date:
- 2021
Materials and methods
- Objective of study:
- other: comparative hydrolysis stability
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The current study was performed to investigate the hydrolytic degradation of the the two test substances “L-Glutamic acid, N-coco acyl derivs. disodium salts” (BASF test substance number 12/0032-3) and “Reaction mass of sodium hydrogen N-(1-oxooctadecyl)-l-glutamate and stearic acid” (BASF test substance number 16/0435-2) in gastric juice simulant and liver S9 fraction of different species.
- GLP compliance:
- yes
Test material
- Reference substance name:
- L-Glutamic acid, N-coco acyl derivs., disodium salts
- EC Number:
- 269-085-1
- EC Name:
- L-Glutamic acid, N-coco acyl derivs., disodium salts
- Cas Number:
- 68187-30-4
- Molecular formula:
- Not applicable (UVCB substance)
- IUPAC Name:
- Disodium (2S)-2-aminopentanedioate
- Details on test material:
- 30-36% active matter
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- other: gastric juice simulant and liver S9 fraction
Results and discussion
Any other information on results incl. tables
When “L-Glutamic acid, N-coco acyl derivs. disodium salts” was incubated in gastric juice simulant, analyzed concentrations of glutamic acid in the incubates (including controls) ranged from 0.352 to 0.935 µg/mL (for incubates with a nominal test substance concentration of 10 ppm) and from 3.807 to 5.204 µg/mL (for incubates with a nominal test substance concentration of 100 ppm). There was no indication for the formation of glutamic acid during incubation of the test substance in gastric juice simulant.
For “Reaction mass of sodium hydrogen N-(1- oxooctadecyl)-l-glutamate and stearic acid”, corresponding values of glutamic acid ranged from 0.097 to 0.436 µg/mL (for incubates with a nominal test substance concentration of 10 ppm) and from 1.102 to 2.891 µg/mL (for incubates with a nominal test substance concentration of 100 ppm). There was no indication for the formation of glutamic acid during incubation of the test substance in gastric juice simulant.
When “L-Glutamic acid, N-coco acyl derivs. disodium salts” was incubated in S9 fraction of rats, rabbits and humans at a test substance concentration of 50 ppm, analyzed concentrations of glutamic acid in the incubates increased generally over time and yielded maximum concentrations of 8.221, 22.549 and 22.008 µg/mL, respectively after 120 min of incubation. For all incubations, buffer controls revealed concentrations of glutamic acid that were ≤ 2.5 µg/mL. For the rat in vitro systems, also medium controls and heat deactivated controls showed concentrations of glutamic acid that were ≤ 2.5 µg/mL. For the rabbit in vitro system, medium controls as well as heat deactivated controls revealed concentrations of glutamic acid of 6.429 and 8.696 µg/mL as well as 7.051 and 8.163 µg/mL. For the human in vitro system, medium controls as well as heat deactivated controls revealed concentrations of glutamic acid of 15.594 and 17.739 µg/mL as well as 16.676 and 17.379 µg/mL. Consequently, the increase of glutamic acid formation in the S9 liver fraction of rats was 5,35 µg/ml after 120 min incubation (see table below), in the S9 liver fraction of rabbits 14,06 µg/ml and in the S9 liver fraction of humans 4,1 µg/ml.
When “Reaction mass of sodium hydrogen N-(1-oxooctadecyl)-l-glutamate and stearic acid” was incubated in S9 fraction of rats, rabbits and humans at a test substance concentration of 50 ppm, analyzed concentrations of glutamic acid in the incubates increased generally over time and yielded maximum concentrations of 7.725, 18.987 and 19.592 µg/mL, respectively after 120 min of incubation. For all incubations, buffer controls revealed concentrations of glutamic acid that were ≤ 2.5 µg/mL. For the rat in vitro systems, also medium controls and heat deactivated controls showed concentrations of glutamic acid that were ≤ 2.5 µg/mL. For the rabbit in vitro system, medium controls as well as heat deactivated controls revealed concentrations of glutamic acid of 6.245 and 8.528 µg/mL as well as 5.992 and 7.183 µg/mL. For the human in vitro system, medium controls as well as heat deactivated controls revealed concentrations of glutamic acid of 16.937 and 17.337 µg/mL as well as 16.309 and 17.387 µg/mL. Consequently, the increase of glutamic acid formation in the S9 liver fraction of rats was 4,86 µg/ml after 120 min incubation (see table below), in the S9 liver fraction of rabbits 11,72 µg/ml and in the S9 liver fraction of humans 2,82 µg/ml.
Taken together, the data of incubations of “L-Glutamic acid, N-coco acyl derivs. disodium salts” and “Reaction mass of sodium hydrogen N-(1-oxooctadecyl)-l-glutamate and stearic acid” in liver S9 fraction demonstrate that glutamic acid formation from both test substances in the applied in vitro systems is comparable. Under the test conditions used, highest amounts of glutamic acid were formed in liver S9 fraction of rabbits. In the liver S9 fractions of rats, the glutamic acid formation was lower than in the rabbit, but comparable for both substances. As the 90 day study and the teratogenicity study were performed with rats, the comparable hydrolysis of the target and the source substance supports the analogue justification (see attached document).
Applicant's summary and conclusion
- Conclusions:
- Taken together, the data of incubations of “L-Glutamic acid, N-coco acyl derivs. disodium salts” and “Reaction mass of sodium hydrogen N-(1-oxooctadecyl)-l-glutamate and stearic acid” in liver S9 fraction demonstrate that glutamic acid is formation from both test susbtances in the applied in vitro systems is comparable. Under the test conditions used, highest amounts of glutamic acid were formed in liver S9 fraction of rabbits. There was no indication for the formation of glutamic acid during incubation of the test substance in gastric juice simulant.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.